Entering text into the input field will update the search result below

ABT, ORFG, GRHU, SPPI, WXS, ULBI - CRWEPicks.com Stock Watch!

May 01, 2011 5:05 PM ET
crwepicks profile picture
crwepicks's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Seeking Alpha Analyst Since 2010



Abbott Laboratories (NYSE:ABT) provides blood glucose monitoring meters, test strips, data management software, and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, lasik surgery, contact lens, and dry eye products. Additionally, ABT engages in the discovery, development, manufacture, and sale of health care products worldwide. Abbott Laboratories operates in four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.


“Low testosterone is a real concern for many men, and it is important that men exhibiting signs and symptoms talk to their doctor about appropriate testing and treatment,” said Natan Bar-Chama, M.D., director of Male Reproductive Medicine and Surgery, The Mount Sinai Hospital in New York. “AndroGel 1.62% is an important new option that was shown in a clinical trial to restore and maintain testosterone levels in men for up to one year.”

Abbott Laboratories disclosed that the U.S. Food and Drug Administration (FDA) has approved AndroGel® (testosterone gel) 1.62%, a clear, odorless, gel formulation shown to restore testosterone levels in hypogonadal men with half the volume of gel at the starting dose compared to AndroGel 1%. At the starting dose, the new AndroGel 1.62% contains 40.5 mg of testosterone in two pump presses, whereas AndroGel 1% contains 50 mg of testosterone in four pump presses.

Dosage and administration for AndroGel 1.62% differs from AndroGel 1% and the two are not interchangeable. Both AndroGel 1.62% and AndroGel 1% are prescription medications used to treat adult males with low or no testosterone, also known as hypogonadism. Nearly 14 million men in the United States may have low testosterone levels. Male hypogonadism (or low testosterone) is a condition in which the body does not produce enough testosterone, the hormone that plays an important role in a man’s growth and development.

Signs and symptoms associated with male hypogonadism include erectile dysfunction and decreased sexual desire, fatigue and loss of energy, depressed mood, osteoporosis and a diminishment in the physical characteristics of a man, such as decreased body hair. The Endocrine Society developed guidelines for the diagnosis and treatment of hypogonadism, which note the normal range for testosterone as 300-1,000 ng/dL.

AndroGel 1.62% is expected to be available to patients in the second quarter of 2011. ABT is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. Abbott Laboratories employs nearly 90,000 people and markets its products in more than 130 countries.

For more information about ABT, please visit: www.abbott.com.



In general, high karat jewelry is softer and more resistant to tarnish while low karat jewelry is stronger and less resistant to tarnish - especially when in contact with perspiration. Orofino Gold Corp. (ORFG) is pleased to announce the appointment of Dr. Hans Bocker as the new Chairman of the Board. Orofino Gold held a Board meeting dated April 5, 2011, to initiate certain corporate changes to the existing members of the Board of Directors. The Board of Directors unanimously appointed Dr. Hans Bocker as the new Chairman of the Board, and the former Chairman, Mr. Ning Shi Long, resigned as Chairman due to personal obligations, but will remain as a member of the Board of Directors.

Dr. Hans J. Bocker is an internationally recognized academic advisor. His expertise encompasses fundamental organizational and operational logistics including production and operations management, purchasing and procurement, safety, loss control, quality management, international management, cross-cultural management, transportation and traffic logistics, and leadership training for executives. In addition to his logistical expertise, Dr. Bocker is also an internationally recognized gold expert. He recently published a book on gold titled Freedom Through Gold which has sold out in several languages.

Dr. Hans J. Bocker is also a published journalist with over 2000 publications. On behalf of the Board of Directors, Orofino Gold wishes to extend their gratitude to Mr. Ning Shi Long for his commitment and efforts as past Chairman of the Board. Orofino Gold is a Colombian based gold producer, founded as a private company in 2009 by former executives with over 50 cumulative years in mining exploration, finance, and development expertise. Orofino Gold’s corporate objective is to continue to build shareholder value through the exploration and development of The Senderos de Oro Gold Camp and additional accretive acquisitions, capitalizing on the extensive experience and relationships that management has developed over the past 25 years.



Together, GreenHouse Holdings, Inc. (OTCBB:GRHU) in partnership with Seychelle Environmental Technologies, Inc., a worldwide leader in the development, assembly and sale of proprietary portable water filtration products, will offer a variety of innovative water filtration and conservation technologies to the Department of Defense. Under the terms of the agreement, Seychelle has chosen GreenHouse Holdings to be its exclusive distributor on Department of Defense RFP’s for which water filtration products are applicable. This will allow GreenHouse Holdings to expand its menu of sustainable products and allow Seychelle to benefit from GreenHouse Holdings’ extensive relationships with high-ranking DOD officials and department heads.

The key to Seychelle portable filtration products is the ability to utilize Ionic Adsorption Micron Technology and BIOSAFE to remove up to 99.99% of pollutants and contaminants found in drinking water supplies; with bacteria and virus removal in these advanced filters to six logs (99.9999%). The filters are made in the USA and have passed the strictest performance tests by government laboratories in the US and sixteen foreign countries using EPA/ANSI protocols, and conforming to NSF Standards 42 and 53. Over 3.5 million filter systems have been sold worldwide to date.

GreenHouse Holdings is a past performance government contractor supplying the US military with a wide range of products from rapidly deployable and ballistically protected buildings to sustainable, environmentally safe targeting systems and live fire training facilities. Effective and portable water filtration is another important step toward a rapidly equipped mobile military. GreenHouse Holdings, Inc. is a leading provider of energy efficiency and sustainable facilities solutions. GreenHouse Holdings designs, engineers and installs disparate products and technologies that enable GreenHouse Holdings’ clients to reduce their energy costs and carbon footprint. GreenHouse Holdings’ target markets for energy efficiency solutions include government and military, as well as commercial, residential and industrial markets. In addition, GreenHouse Holdings develops, designs and constructs rapidly deployable, sustainable facilities primarily for use in disaster relief and security in austere regions.


Spectrum Pharmaceuticals (Nasdaq:SPPI) reported that the U.S. Food and Drug Administration (FDA) has approved the Company’s Supplemental New Drug Application for FUSILEV® (levoleucovorin) Injection. Unlike the currently available lyophilized product, this approval is for a “Ready-to-Use” formulation of FUSILEV® (levoleucovorin) for Injection.

Spectrum Pharmaceuticals, Inc. operates as a commercial-stage biotechnology company with a primary focus in oncology and hematology. The company engages in acquiring, developing, and commercializing a broad and diverse pipeline of late-stage clinical and commercial products.


Wright Express Corporation (NYSE:WXS) will report first-quarter 2011 financial results before the market opens on Wednesday, May 4, 2011. Michael Dubyak, Chief Executive Officer, and Steve Elder, Chief Financial Officer, will host a conference call that morning at 10:00 a.m. ET to discuss the Company's results.

Wright Express Corporation, together with its subsidiaries, provides payment processing and information management products and services to the commercial and government vehicle fleet industry in the United States, Canada, New Zealand, Australia, and Europe.


Ultralife Corporation (NASDAQ:ULBI) will report its first quarter results for the period ended April 3, 2011 before the market opens on Thursday, May 5, 2011. Ultralife’s management will host an investor conference call at 10:00 AM ET also on May 5, 2011.

Ultralife Corporation offers products and services ranging from portable and standby power solutions to communications and electronics systems worldwide. It serves government, defense, and commercial customers through its engineering and collaborative approach to problem solving.

Sign-Up For Free Stock Alerts At http://crwepicks.com/signup

business Card 3



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.The CRWEPicks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer (http://crwepicks.com/disclaimer ) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEPicks.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. ( read more at http://crwepicks.com/disclaimer ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings, Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings, Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has previously received 500,000 shares of (144) restricted common stock and 500,000 shares of free trading shares from a third party (QU CUI You) for six months of advertisement services (which has expired) for Orofino Gold Corp. (PINK SHEETS:ORFG). Crown Equity Holdings Inc. (OTCPK:CRWE) has received fifteen thousand dollars in cash and anticipates another five thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU.OB). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also has received 20,000 shares of 144 restricted stocks from the company.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.